✦ LIBER ✦

De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection

✍ Scribed by Jose L. Tovar; Maria Buti; Alfonso Segarra; Joaquim Majó; Rafael Esteban

Book ID: 106554991
Publisher: Springer Netherlands
Year: 2007
Tongue: English
Weight: 126 KB
Volume: 40
Category: Article
ISSN: 0301-1623
DOI: 10.1007/s11255-007-9241-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nephrotic syndrome with pegylated interf

Nephrotic syndrome with pegylated interferon alfa 2a and ribavirin for a patient with chronic hepatitis C

✍ Ajit Sood; Vandana Midha; Jaswinder S. Sandhu; Neena Sood; Amarjit Kaur; Rasham 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 69 KB

r-interferon alfa–2b/ribavirin combined

r-interferon alfa–2b/ribavirin combined therapy followed by low-dose r-Interferon alfa-2b in chronic hepatitis C interferon nonresponders

✍ A. Perasso; G. Testino; F. Ansaldi; V. Venturino; G.C. Icardi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

Pegylated interferon and ribavirin thera

Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection

✍ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-Sauné; J.P. Vinel; L. A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCV‐4 responds poorly to interferon. Pegylated

Incidence of Neutropenia and Infections

Incidence of Neutropenia and Infections During Combination Treatment of Chronic Hepatitis C with Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin

✍ M. G. Antonini; S. Babudieri; I. Maida; C. Baiguera; B. Zanini; L. Fenu; G. Dett 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 271 KB

Changes in haemoglobin during interferon

Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection

✍ M. S. Sulkowski; R. Wasserman; L. Brooks; L. Ball; R. Gish 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Eicosapentaenoic Acid Supplementation fo

Eicosapentaenoic Acid Supplementation for Chronic Hepatitis C Patients During Combination Therapy of Pegylated Interferon α-2b and Ribavirin

✍ Aiko Kawashima; Ikuyo Tsukamoto; Tomoko Koyabu; Yasuko Murakami; Takayo Kawakami 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 255 KB